Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    20185168 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer
Conditions: Epithelial Ovarian Cancer;   Peritoneal Neoplasms;   Fallopian Tube Neoplasms
Intervention: Drug: Birinapant (TL32711)

Study has passed its completion date and status has not been verified in more than two years.